Microbiological and molecular assessment of bacteriophage ISP for the control of Staphylococcus aureus.

Microbiological and molecular assessment of bacteriophage ISP for the control of Staphylococcus aureus.

The increasing antibiotic resistance in bacterial populations requires alternatives for classical treatment of infectious diseases and therefore drives the renewed interest in phage therapy. Methicillin resistant Staphylococcus aureus (MRSA) is a major problem in health care settings and live-stock...

Full description

Bibliographic Details
Main Authors:	Katrien Vandersteegen, Wesley Mattheus, Pieter-Jan Ceyssens, Florence Bilocq, Daniel De Vos, Jean-Paul Pirnay, Jean-Paul Noben, Maia Merabishvili, Urszula Lipinska, Katleen Hermans, Rob Lavigne
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2011-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3170307?pdf=render

Similar Items

Characterization of newly isolated lytic bacteriophages active against Acinetobacter baumannii.
by: Maia Merabishvili, et al.
Published: (2014-01-01)

The bacteriophage LUZ24 “Igy” peptide inhibits the Pseudomonas DNA gyrase
by: Jeroen De Smet, et al.
Published: (2021-08-01)

Phenotypic and genotypic variations within a single bacteriophage species
by: Kulakov Leonid, et al.
Published: (2011-03-01)

T4-related bacteriophage LIMEstone isolates for the control of soft rot on potato caused by 'Dickeya solani'.
by: Evelien M Adriaenssens, et al.
Published: (2012-01-01)

Stability of bacteriophages in burn wound care products.
by: Maia Merabishvili, et al.
Published: (2017-01-01)

Structural elucidation of a novel mechanism for the bacteriophage-based inhibition of the RNA degradosome
by: An Van den Bossche, et al.
Published: (2016-07-01)

Isolation and Characterization of Lytic <i>Pseudomonas aeruginosa</i> Bacteriophages Isolated from Sewage Samples from Tunisia
by: Ismahen Akremi, et al.
Published: (2022-10-01)

Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials.
by: Maya Merabishvili, et al.
Published: (2009-01-01)

Characterization of a Bacteriophage GEC_vB_Bfr_UZM3 Active against <i>Bacteroides fragilis</i>
by: Nata Bakuradze, et al.
Published: (2023-04-01)

Bacteriophage Application for Difficult-to-treat Musculoskeletal Infections: Development of a Standardized Multidisciplinary Treatment Protocol
by: Jolien Onsea, et al.
Published: (2019-09-01)

Evaluation of the Stability of Bacteriophages in Different Solutions Suitable for the Production of Magistral Preparations in Belgium
by: Hans Duyvejonck, et al.
Published: (2021-05-01)

Design and Validation of RT-PCR Assays to Differentiate <i>Salmonella</i> Vaccine Strains from Wild-Type Field Isolates
by: Pieter-Jan Ceyssens, et al.
Published: (2024-03-01)

Characterization of <i>Salmonella</i> Isolates from Various Geographical Regions of the Caucasus and Their Susceptibility to Bacteriophages
by: Khatuna Makalatia, et al.
Published: (2020-12-01)

The Magistral Phage
by: Jean-Paul Pirnay, et al.
Published: (2018-02-01)

ISP Distillation
by: Eli Schwartz, et al.
Published: (2023-01-01)

ISP shining !!!
by: Lalit Kumar Mathur
Published: (2011-01-01)

ISP survival guide : strategies for running a competitive ISP /
by: 258635 Huston, Geoff
Published: (1999)

The T7-related Pseudomonas putida phage φ15 displays virion-associated biofilm degradation properties.
by: Anneleen Cornelissen, et al.
Published: (2011-01-01)

Bacteriophage Therapy for Difficult-to-Treat Infections: The Implementation of a Multidisciplinary Phage Task Force (<i>The PHAGEFORCE Study Protocol</i>)
by: Jolien Onsea, et al.
Published: (2021-08-01)

Use of bacteriophages in the treatment of colistin-only-sensitive Pseudomonas aeruginosa septicaemia in a patient with acute kidney injury—a case report
by: Serge Jennes, et al.
Published: (2017-06-01)

Bacteriophage-antibiotic combination therapy against extensively drug-resistant Pseudomonas aeruginosa infection to allow liver transplantation in a toddler
by: Brieuc Van Nieuwenhuyse, et al.
Published: (2022-09-01)

ISP Scientific Events
Published: (2023-01-01)

ISP Scientific Events
Published: (2023-01-01)

ISP Scientific Events
Published: (2022-01-01)

ISP scientific events
Published: (2023-01-01)

ISP Scientific Events
Published: (2022-01-01)

ISP scientific events
Published: (2022-01-01)

Exploiting phage-antibiotic synergies to disrupt Pseudomonas aeruginosa PAO1 biofilms in the context of orthopedic infections
by: Steven De Soir, et al.
Published: (2024-01-01)

Biology and Genomics of an Historic Therapeutic Escherichia coli Bacteriophage Collection
by: Abiyad Baig, et al.
Published: (2017-08-01)

The Interoperable Systems Project (ISP)
by: Chris Allen
Published: (1994-03-01)

Pseudomonas aeruginosa population structure revisited.
by: Jean-Paul Pirnay, et al.
Published: (2009-11-01)

The Unique Role That WHO Could Play in Implementing Phage Therapy to Combat the Global Antibiotic Resistance Crisis
by: Alan Fauconnier, et al.
Published: (2020-09-01)

Screening of Anorectal and Oropharyngeal Samples Fails to Detect Bacteriophages Infecting <i>Neisseria gonorrhoeae</i>
by: Jolein Gyonne Elise Laumen, et al.
Published: (2022-02-01)

Successful Bacteriophage-Antibiotic Combination Therapy against Multidrug-Resistant <i>Pseudomonas aeruginosa</i> Left Ventricular Assist Device Driveline Infection
by: Karlis Racenis, et al.
Published: (2023-05-01)

The potential of bacteriophages to control Xanthomonas campestris pv. campestris at different stages of disease development
by: Dominique Holtappels, et al.
Published: (2022-06-01)

Impact of ISP Tuning on Object Detection
by: Dara Molloy, et al.
Published: (2023-11-01)

THE ISPS CODE AND IT’S IMPLEMENTATION IN MALAYSIA
by: Nurul Huda Ahmad Razali, et al.
Published: (2014-04-01)

Enhancing ISP-consumer security notifications
by: Fruchter. Nathaniel H.
Published: (2019)

Regulating Monopolistic ISPS without Neutrality
by: Tang, Jing, et al.
Published: (2016)

ISP Colloquium Series - 2014, Bangalore
Published: (2014-01-01)